Last updated 2026-06-18
- Raised $1.4M funding round, Jun 2023
- Raised $500k grant led by Israel Innovation Authority , Apr 2023
- Raised $800k funding round, Jan 2022
Total raised
$2.7M
Last: 2023-06
Stage
Pre-Seed
Founded
2021
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
SignaLife is a technology company developing lifesaving AI optic sensors for medical and well-being use. The company’s products are designed to provide non-invasive and continuous pH and Blood Gases for patients hospitalized in the ICU and NICU (neonatal ICU).
Initial results from the company’s first in human trial in Assuta Ashdod ICU, showing high accuracy in testing pH, pCO2, Bi-carbonate (HCO3) and lactate. First baby in the 2nd clinical trial in Sheba Medical Center’s NICU was recruited during April 2025 with promising pH results.
SignaLife’s solutions address the need for non-invasive, reliable measurements, reducing infection risk, minimizing blood draws, and supporting better treatment decisions.
Funding history · 3 rounds · $2.7M total
Q&A
- What is SignaLife's primary focus?
- SignaLife is a technology company developing non-invasive continuous blood gas and pH sensors using AI optic technology for medical and well-being use.
- What is the status of SignaLife's clinical trials?
- SignaLife has shown high accuracy in initial results from its first in human trial in Assuta Ashdod ICU. A second clinical trial in Sheba Medical Center’s NICU recruited its first baby in April 2025, with promising pH results.
- What is SignaLife's total funding to date?
- SignaLife has raised a total of $2,700,000 across multiple funding rounds.
- When was SignaLife founded?
- SignaLife was founded in March 2021.
- Which investors have participated in SignaLife's funding rounds?
- In April 2023, SignaLife received a grant from the Israel Innovation Authority.
- What is SignaLife's current employee count?
- SignaLife currently has 1-10 employees.
- Who are the co-founders of SignaLife?
- The co-founders of SignaLife are Yaron Cherny, who serves as CEO, and Roy Nissim, who serves as CSO.
- What problem do SignaLife's solutions address?
- SignaLife's solutions aim to provide non-invasive, reliable measurements, reducing infection risk, minimizing blood draws, and supporting better treatment decisions for patients hospitalized in the ICU and NICU.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Technologies
Artificial IntelligenceSensing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-devicesmonitoring
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | signalife.com/ |
|---|---|
| linkedin.com/company/101222372/ |
Identifiers & details
| Founded | 2021-3 |
|---|---|
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 6 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | signalife.com |
|---|